EGATEN 250 mg/1
triclabendazole · TABLET · Novartis Pharmaceuticals Corporation
No Recall History
Plain English
EGATEN is a tablet containing triclabendazole at 250 mg/1, taken oral. Manufactured by Novartis Pharmaceuticals Corporation.
Key Facts
- Brand Name
- EGATEN
- Generic Name
- triclabendazole
- NDC Code (Product)
0078-0937- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 250 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA208711
- Drug Class
- Anthelmintic [EPC]
- Marketing Start
- 02/13/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is EGATEN used for?
EGATEN contains triclabendazole. It is a tablet taken oral. Consult your doctor for specific uses.
Is EGATEN a controlled substance?
EGATEN is not classified as a controlled substance by the DEA.
What is the generic name for EGATEN?
The generic name for EGATEN is triclabendazole. There are no other listed brand versions of triclabendazole.
What is the NDC code for EGATEN 250 mg/1?
The NDC (National Drug Code) for EGATEN 250 mg/1 is 0078-0937, listed by Novartis Pharmaceuticals Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)